Cite
HARVARD Citation
Yamamoto, K. et al. (2021). ALK‐positive lung cancer in a patient with recurrent brain metastases and meningeal dissemination who achieved long‐term survival of more than seven years with sequential treatment of five ALK‐inhibitors: A case report. Thoracic cancer. 12 (11), pp. 1761-1764. [Online].